The Bio Report
The Bio Report

California, Aid-in-Dying, and What We’ve Learned from Oregon

The California legislature earlier this month passed a bill that would allow physicians to aid terminally ill patients who wanted to end their lives. California would become the fifth state to enact such legislation. We spoke to David Grube, national medical director of Compassion & Choices, a n

Featured Speakers

Levine Media Group HostDavid Grubb Guest

Topics Discussed

Episode Summary

Executive Summary: The episode examines California’s physician-assisted dying bill through a detailed interview with Compassion & Choices’ David Grubb. He explains how the law mirrors Oregon’s model, argues that experience shows it has not produced feared abuses, and says public and physician support have grown as patient autonomy and end-of-life suffering have become more openly discussed.

Main Topics: California’s assisted-dying legislation (Priority: 5/5): Grubb explains that the California bill closely follows Oregon’s Death with Dignity law, allowing mentally capable terminally ill adults with less than six months to live to request life-ending medication. Legal status and safeguards (Priority: 5/5): The discussion covers who qualifies, the role of physician prescribing, the requirement of terminal illness and capacity, and the distinction between lawful aid in dying and prohibited wrongdoing in other states. Impact of Brittany Maynard on the movement (Priority: 4/5): Maynard’s public story is presented as a turning point that personalized the issue, accelerated national conversation, and increased visibility for end-of-life choice. Evidence from Oregon’s long-term experience (Priority: 5/5): Grubb argues that 17-plus years of Oregon data show the law is rarely used, has not expanded beyond its original scope, and has not generated predicted negative consequences. Changing public and physician attitudes (Priority: 4/5): He says polling shows major growth in support among both the public and physicians, driven by greater awareness of suffering, patient autonomy, and limits of medical cure. Language, ethics, and the meaning of death (Priority: 4/5): A major segment distinguishes aid in dying from suicide, discusses death certificate practices, and emphasizes that terminology shapes public understanding and families’ experiences. Broader cultural shift around mortality (Priority: 3/5): The conversation closes by linking the debate to an aging population and a growing willingness to talk about death, fueled by works like Being Mortal and Dying in America.

Key Arguments: California’s bill is modeled almost exactly on Oregon’s law, which allows competent adults with a terminal diagnosis and less than six months to live to request medication. Aid in dying is presented as a patient-autonomy issue: the individual, not the physician or insurer, should decide whether to use the option. Oregon’s long-term experience is used as evidence that predicted harms have not materialized, with no erosion of the law and no broadening to other circumstances. The law is described as rarely used, suggesting it functions as an option of control more than a common end-of-life practice. One-third of patients who obtain the medication do not take it, implying that the availability of the option itself provides comfort and control. Public and physician support have increased substantially, which Grubb attributes to better understanding of suffering and the limits of medicine. Grubb argues that aid in dying differs fundamentally from suicide because the patients are terminally ill, not mentally ill, and the choice is deliberate, non-violent, and family-centered.

Data Points: States with legal aid in dying: 5 - Grubb says California would become the fifth state to enact such legislation. Age requirement: 18 years or older - Oregon-style law requires an adult resident to qualify. Terminal prognosis: Less than 6 months to live - Eligibility standard described in the Oregon statute and California bill. Oregon law year enacted: 1997 - Grubb references the original Oregon statute. Oregon annual usage: 100 times last year - He cites this as evidence the law is rarely used. Total deaths in Oregon: 34,000 deaths - Used to contextualize how uncommon aid in dying is relative to overall mortality. Public support: 70% and more - Grubb says polling now shows broad national support for aid in dying. Physician support: Majority of physicians - He says physician polling last December showed majority support, reversing earlier minority support. Unused prescriptions: About one-third - He says roughly one-third of patients who receive lethal medication do not take it. Oregon experience duration: 17-18 years - Grubb repeatedly refers to the law’s long track record and data over that period. Population aging projection: As many 80-year-olds as 5-year-olds within 30 years - He cites this to explain why death and end-of-life issues are becoming more prominent.

Pivotal Quotes: "“none of the arguments opposed to aid in dying have come to fruition.”" — David Grubb: Summarizing Oregon’s long-term results and defending the law’s safety record. "“Aid in dying patients do not have a mental diagnosis. They are dying. They want to live.”" — David Grubb: Explaining why he rejects the term suicide for terminally ill patients using the law. "“we’re seeing that aid in dying is not increasing the number of people who are dying. It’s just decreasing the number of people who are suffering.”" — David Grubb: Describing the ethical rationale and intended effect of the policy.

Implications: The interview suggests assisted dying is moving from a fringe controversy toward a normalized end-of-life option, backed by data, public support, and changing clinical attitudes. For listeners, the key takeaway is that autonomy and suffering relief are increasingly shaping policy debates.

🔓 Sign Up for Unlimited Episode Search

About The Bio Report

The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.

View all episodes from The Bio Report